Men are also at risk from breast cancer. Philippine General Hospital (PGH) Cancer Institute Chairman Dr. Jorge Ignacio on Thursday, March 23, admitted that there is no sufficient data to thoroughly understand the occurrence of breast cancer among men. “We know too little about the biology of breast cancer in men. It only covers one percent of breast cancer patients so there is not enough research on that,” said Ignacio in a forum held Thursday. The World Health Organization (WHO) previously disclosed that one in every 100 breast cancer cases is found in a man. Male breast cancer tends to be rare, but experts said it is more fatal in men than women. “Walang big clinical trials on breast cancer in men kasi hindi [makakuha] ng maraming pasyente to make a standardized treatment. We try to equate kung ano ang treatment namin sa babae and of course that's [not enough] (There are no big clinical trials on breast cancer in men because they cannot gather enough patients to make a standardized treatment. We try to equate their  treatment with women and of course that is not enough),” Ignacio explained. “But then, we have no other way — we also try to use hormonal treatment, but we're not really sure if it's gonna work. Not with concrete certainty that it's the right medicine for them,” he furthered. In hopes of shedding light on this matter, Ignacio said PGH is “banking” all data found among the institute’s male cancer patients. “Yan ang ginagawa namin ngayon sa PGH. We are banking all those. Marami kaming hindi alam sa male breast cancer — [from] what triggered it, anong treatment talaga dyan na optimum (That’s what we are doing in PGH. We are banking all those. We don’t know much about male breast cancer — from what triggered it or what optimum treatments work),” he concluded.